This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Vosevi
  • /
  • Safety and Efficacy of SOF/VEL/VOX FDC for 8 Weeks...
Clinical trial

Safety and Efficacy of SOF/VEL/VOX FDC for 8 Weeks and SOF/VEL for 12 Weeks in Adults Chronic Genotype 3 HCV Infection and Cirrhosis

Read time: 3 mins
Last updated:1st Nov 2015
Identifier: NCT02639338
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest